Next Article in Journal
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Next Article in Special Issue
Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Previous Article in Journal
A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations
Previous Article in Special Issue
Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6126; https://doi.org/10.3390/cancers14246126
Action Date Notes Link
article pdf uploaded. 12 December 2022 14:14 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6126/pdf-vor
article xml file uploaded 20 December 2022 04:17 CET Original file -
article xml uploaded. 20 December 2022 04:17 CET Update https://www.mdpi.com/2072-6694/14/24/6126/xml
article pdf uploaded. 20 December 2022 04:17 CET Updated version of record https://www.mdpi.com/2072-6694/14/24/6126/pdf
article html file updated 20 December 2022 04:18 CET Original file -
article html file updated 4 March 2023 21:06 CET Update https://www.mdpi.com/2072-6694/14/24/6126/html
Back to TopTop